Nagy Z, Hindley N J, Braak H, Braak E, Yilmazer-Hanke D M, Schultz C, Barnetson L, King E M, Jobst K A, Smith A D
OPTIMA, Departments of Pharmacology and Neuropathology, Department of Pharmacology, University of Oxford, UK.
Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):115-20. doi: 10.1159/000017111.
Alzheimer's disease (AD) is characterised by the gradual accumulation of neurofibrillary pathology in selected regions of the brain. Earlier studies indicate that the accumulation of neurofibrillary tangles is associated both with decline in patient's cognitive performance as well as with medial temporal lobe atrophy on CT scans. There are also indications that progression through the pathological stages of AD is associated with decline in cognitive functions. The results of this study indicate that progression of disease, especially beyond the boundaries of the limbic regions, is associated with marked decline in the cognitive performance of patients suffering from AD. However the clinical manifestations of early pathological stages are not so well defined. We also found that the atrophy of the medial temporal lobe on CT scans is related to the progression of pathology. Atrophy is most apparent when the disease reaches its isocortical stages and is not marked in the limbic stages of the disease. The additive effect of pathologies co-existing with AD is apparent in reduced cognitive scores, while the atrophy of limbic structures, as measured on CT scans, seems to be mainly attributable to AD-related pathology.
阿尔茨海默病(AD)的特征是大脑特定区域神经纤维病理改变逐渐累积。早期研究表明,神经纤维缠结的累积与患者认知功能下降以及CT扫描显示的内侧颞叶萎缩均有关联。也有迹象表明,AD病理阶段的进展与认知功能下降相关。本研究结果表明,疾病进展,尤其是超出边缘区域范围时,与AD患者的认知功能显著下降有关。然而,早期病理阶段的临床表现尚不明确。我们还发现,CT扫描显示的内侧颞叶萎缩与病理进展有关。当疾病发展到等皮质阶段时萎缩最为明显,而在疾病的边缘阶段则不明显。与AD共存的病理改变的叠加效应在认知评分降低方面较为明显,而CT扫描测量的边缘结构萎缩似乎主要归因于AD相关病理改变。